Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Litzow

Showing results (181-190 of 457) with videos related to

Pageof 46
Sort By:
British Journal of Haematology|October 31, 2017
Efficacy of biological agents in the treatment of Erdheim-Chester diseaseGaurav Goyal, Mithun V Shah, Timothy G Call, et al.
Blood Advances|May 6, 2022
Relationship of iothalamate clearance and NRM in patients receiving fludarabine and melphalan reduced-intensity conditioningJade L Kutzke, Julianna A Merten, Amanda G Pawlenty, et al.
Journal of Cutaneous Pathology|September 15, 2017
Immunophenotypic and molecular comparison between allogeneic and autologous graft-vs-host disease of the skin: A retrospective study using immunohistochemical and proteomics methodsJulia S Lehman, Shahrukh K Hashmi, Hillard M Lazarus, et al.
The New England Journal of Medicine|September 25, 2009
Anthracycline dose intensification in acute myeloid leukemiaHugo F Fernandez, Zhuoxin Sun, Xiaopan Yao, et al.
BMC Hematology|September 16, 2014
Impact of clinical factors and allograft leukocyte content on post-transplant lymphopenia, monocytopenia, and survival in patients undergoing allogeneic peripheral blood haematopoietic cell transplantMary D Thoma, Jennifer Glejf, Eapen Jacob, et al.
American Journal of Hematology|February 2, 2021
Acute myeloid leukemia after age 70 years: A retrospective comparison of survival following treatment with intensive versus HMA ± venetoclax chemotherapyKebede H Begna, Naseema Gangat, Aref Al-Kali, et al.
Bone Marrow Transplantation|April 3, 2023
Factors predicting survival following alloSCT in patients with therapy-related AML and MDS: a multicenter studyAnmol Baranwal, Rakchha Chhetri, David Yeung, et al.
Blood Advances|November 27, 2023
Genetic features and outcomes of allogeneic transplantation in patients with WT1-mutated myeloid neoplasmsAnmol Baranwal, Rami Basmaci, Rong He, et al.
Haematologica|February 27, 2025
Molecular Predictors of Response and Survival in Patients with Relapsed/Refractory Acute Myeloid Leukemia following Venetoclax plus Hypomethylating Agent TherapyIsla M Johnson, Rimal Ilyas, Kristen McCullough, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 31, 2016
Extramedullary Disease in Adult Acute Myeloid Leukemia Is Common but Lacks Independent Significance: Analysis of Patients in ECOG-ACRIN Cancer Research Group Trials, 1980-2008Chezi Ganzel, Judith Manola, Dan Douer, et al.
Pageof 46

Showing results (181-190 of 457) with videos related to

Sort By:
Pageof 46
British Journal of Haematology|October 31, 2017
Efficacy of biological agents in the treatment of Erdheim-Chester diseaseGaurav Goyal, Mithun V Shah, Timothy G Call, et al.
Blood Advances|May 6, 2022
Relationship of iothalamate clearance and NRM in patients receiving fludarabine and melphalan reduced-intensity conditioningJade L Kutzke, Julianna A Merten, Amanda G Pawlenty, et al.
Journal of Cutaneous Pathology|September 15, 2017
Immunophenotypic and molecular comparison between allogeneic and autologous graft-vs-host disease of the skin: A retrospective study using immunohistochemical and proteomics methodsJulia S Lehman, Shahrukh K Hashmi, Hillard M Lazarus, et al.
The New England Journal of Medicine|September 25, 2009
Anthracycline dose intensification in acute myeloid leukemiaHugo F Fernandez, Zhuoxin Sun, Xiaopan Yao, et al.
BMC Hematology|September 16, 2014
Impact of clinical factors and allograft leukocyte content on post-transplant lymphopenia, monocytopenia, and survival in patients undergoing allogeneic peripheral blood haematopoietic cell transplantMary D Thoma, Jennifer Glejf, Eapen Jacob, et al.
American Journal of Hematology|February 2, 2021
Acute myeloid leukemia after age 70 years: A retrospective comparison of survival following treatment with intensive versus HMA ± venetoclax chemotherapyKebede H Begna, Naseema Gangat, Aref Al-Kali, et al.
Bone Marrow Transplantation|April 3, 2023
Factors predicting survival following alloSCT in patients with therapy-related AML and MDS: a multicenter studyAnmol Baranwal, Rakchha Chhetri, David Yeung, et al.
Blood Advances|November 27, 2023
Genetic features and outcomes of allogeneic transplantation in patients with WT1-mutated myeloid neoplasmsAnmol Baranwal, Rami Basmaci, Rong He, et al.
Haematologica|February 27, 2025
Molecular Predictors of Response and Survival in Patients with Relapsed/Refractory Acute Myeloid Leukemia following Venetoclax plus Hypomethylating Agent TherapyIsla M Johnson, Rimal Ilyas, Kristen McCullough, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 31, 2016
Extramedullary Disease in Adult Acute Myeloid Leukemia Is Common but Lacks Independent Significance: Analysis of Patients in ECOG-ACRIN Cancer Research Group Trials, 1980-2008Chezi Ganzel, Judith Manola, Dan Douer, et al.
Pageof 46